As of 2026-03-24, the Intrinsic Value of Cogent Biosciences Inc (COGT) is -10.13 USD. This COGT valuation is based on the model Peter Lynch Fair Value. With the current market price of 35.41 USD, the upside of Cogent Biosciences Inc is -128.62%.
Based on its market price of 35.41 USD and our intrinsic valuation, Cogent Biosciences Inc (COGT) is overvalued by 128.62%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -10.13 - -10.13 | -10.13 | -128.62% |
| P/E | (45.15) - (51.88) | (47.12) | -233.1% |
| DDM - Stable | (22.18) - (97.55) | (59.87) | -269.1% |
| DDM - Multi | (7.77) - (27.06) | (12.13) | -134.3% |
| Market Cap (mil) | 5,747.40 |
| Beta | 1.31 |
| Outstanding shares (mil) | 162.31 |
| Enterprise Value (mil) | 5,658.28 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.13% |
| Cost of Debt | 5.00% |
| WACC | 7.96% |